Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients (Q45203630)

10 December 2017

title

Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients (English)

1 reference

pharmaceutical preparation of nitroglycerin

10 December 2017

0 references

1 reference

S Levacher

1 reference

10 December 2017

P Letoumelin

1 reference

10 December 2017

D Pateron

1 reference

10 December 2017

M Blaise

1 reference

10 December 2017

C Lapandry

1 reference

10 December 2017

J L Pourriat

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

10 December 2017

1 reference

inferred from page(s)

published in

The Lancet

1 reference

10 December 2017

volume

346

1 reference

10 December 2017

issue

8979

1 reference

10 December 2017

page(s)

865-868

1 reference

Morbidity and mortality of portal hypertension.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992708-5

7 January 2021

10.1016/S0140-6736(95)92708-5

Identifiers

DOI

1 reference

10 December 2017

1 reference